CBS News - Search News

FDA orders new warning on GLP-1 drugs

GLP-1 drugs, popular for weight loss, get FDA warning of rare vision-loss side effect

Popular weight loss and diabetes drugs, including Ozempic and Wegovy, will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulator...

Continue reading

· 6h · on MSN

FDA tells GLP-1 makers to warn of potential vision loss side effect

· 8h · on MSN

FDA says popular GLP-1 drugs linked to rare risk of vision loss, blindness

GLP-1 drugs getting new labels warning of rare vision-loss condition

The FDA is adding new warning labels to GLP-1 drugs regarding a condition that could lead to vision loss.

Continue reading

NBC Los Angeles · 5h

FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness

FDA adds warning about rare vision loss to popular GLP-1s